
8 years ago
Insights about prostate cancer resistance could lead to treatment strategies
In the journal Molecular Cell, researchers led by G. Greg Wang, PhD, Associate Professor of Biochemistry and Biophysics, and H. Shelton Earp, MD, describe the role of a protein variant called androgen receptor variant 7 (AR-V7), which is an alternative form of the androgen receptor that plays a key role in prostate cancer development and treatment.









